PCs can lose CD19 antigen expression during differentiation [99]; however, neoplastic PCs can retain their expression, thus explaining the potential use of anti-CD19 CAR-T cell therapy in MM [137,138]. Here, CD19 is linked to Miyoshi myopathy.